Dapagliflozin + Metformin

Dapagliflozin + Metformin
Product Description

Dapagliflozin and Metformin Hydrochloride Fixed-Dose Combination Tablets (typically formulated as Extended-Release or XR) are high-potency oral antihyperglycemic medications prescribed to manage blood glucose levels in adults with Type 2 Diabetes Mellitus (T2DM). This therapeutic pairing merges two distinct mechanisms of action into a single daily tablet to maximize glycemic control while supporting cardiovascular health.

Swiftmed International Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2026
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Specifications
  • Details
    Active Ingredients: Dapagliflozin combined with Metformin Hydrochloride in variable strengths: 500 mg, 850 mg, or 1000 mg.Therapeutic Class: Dual-action combination containing a Sodium-Glucose Cotransporter 2 (SGLT2) inhibitor and a Biguanide.Pharmaceutical Form: Film-coated, extended-release (XR) or immediate-release oral tablets.Packaging Configurations: Typically packed in blister packages of 30, 60, or 100 units to maintain product freshness and stability. 

Swiftmed International Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2026
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)

More Products from Swiftmed International Private Limited (99)

  • Clozapine

    Product Clozapine

    The product consists of a chemical compound categorized as a second-generation (atypical) antipsychotic, designed to balance dopamine and serotonin pathways in the central nervous system to regulate advanced thinking, mood, and behavior. It is manufactured as a strictly monitored prescription-only treatmen...
  • Colistimethate Sodium for Injection

    Product Colistimethate Sodium for Injection

    Colistimethate Sodium for Injection USP/IP (4.5 MIU) is a high-potency, last-resort polypeptide antibiotic prescribed to treat severe, multi-drug resistant (MDR) Gram-negative bacterial infections. Supplied as a sterile, preservative-free lyophilized (freeze-dried) powder cake, it acts as a critical care "...
  • Cyclosporine Eye Emulsion

    Product Cyclosporine Eye Emulsion

    Cyclosporine Ophthalmic Emulsion 0.05% is a prescription topical immunomodulator designed to increase tear production in patients suffering from keratoconjunctivitis sicca (chronic dry eye disease). By delivering a precise micro-emulsion of an immunosuppressive calcineurin inhibitor to the ocular surface, ...
  • Dabigatran Etexilate Mesylate

    Product Dabigatran Etexilate Mesylate

    Dabigatran etexilate mesylate is a prescription oral anticoagulant medication used to prevent and treat serious blood clots. It belongs to the class of modern blood thinners known as Direct Oral Anticoagulants (DOACs), operating as a direct thrombin inhibitor rather than targeting factor Xa
  • Daclatasvir

    Product Daclatasvir

    Daclatasvir 60 mg is a prescription direct-acting antiviral (DAA) medication used in combination with other antiviral agents to treat chronic hepatitis C virus (HCV) infections. It targets the virus directly to prevent replication and assembly
  • Dapagliflozin

    Product Dapagliflozin

    Dapagliflozin is a prescription medication used to manage type 2 diabetes, reduce the risk of heart failure hospitalization, and slow the progression of chronic kidney disease. It belongs to the class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors.
  • Desvenlafaxine

    Product Desvenlafaxine

    Desvenlafaxine ER (Extended-Release) is a prescription antidepressant medication belonging to the serotonin-norepinephrine reuptake inhibitor (SNRI) class. It is primarily prescribed under brand names like Pristiq to treat Major Depressive Disorder (MDD) in adults
  • Diatrizoate Meglumine And Diatrizoate Sodium USP

    Product Diatrizoate Meglumine And Diatrizoate Sodium USP

    Diatrizoate Meglumine and Diatrizoate Sodium Injection USP is a high-potency, ionic, iodinated radiopaque contrast agent designed for diagnostic intravascular and diagnostic imaging procedures. Formulated as a sterile aqueous solution, it provides optimal tissue opacification by leveraging a high concentra...
  • Diclofenac Sodium + Pridinol

    Product Diclofenac Sodium + Pridinol

    Diclofenac sodium combined with pridinol is a fixed-dose combination medication used to treat painful muscle spasms associated with joint or back conditions. The diclofenac component acts as a nonsteroidal anti-inflammatory drug (NSAID) to reduce pain and inflammation, while pridinol acts as a central musc...
  • Divalproex Sodium

    Product Divalproex Sodium

    Divalproex sodium is an oral prescription anticonvulsant and mood-stabilizing medication formulated as a stable coordination compound of sodium valproate and valproic acid
  • Duloxetine

    Product Duloxetine

    Duloxetine Delayed-Release Capsules are an oral prescription medication classified as a serotonin-norepinephrine reuptake inhibitor (SNRI). The product consists of a gelatin capsule shell containing enteric-coated pellets of duloxetine hydrochloride. This special delayed-release mechanism protects the acti...
  • Empagliflozin + Linagliptin

    Product Empagliflozin + Linagliptin

    Empagliflozin combined with linagliptin is a prescription oral medication used to improve blood sugar control in adults with type 2 diabetes. It is a fixed-dose combination that pairs two distinct, non-insulin mechanisms of action to manage glucose levels effectively.

Swiftmed International Private Limited resources (1)